AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
#82 – ID Literature Year in Review (LIVE from MAD-ID)
Breakpoints
Laetermivir Versus Valgand Cyclovir for Prevention of CMV Disease in High Risk Kidney Transplant Patients
The study was looking at Laetermivir versus Valgand cyclovir for the prevention of CMV disease in high risk kidney transplant patients. So this is where your donor is CMV positive and you as the transplant recipient are CMV negative. That makes you very high risk for developing disease. And they looked at the primary endpoint ofCMV disease through 28 weeks and then at a year so this is the 52 week mark and there was no difference. This held true for all pre-specified subgroups including patients that got lymphocyte depleting induction with either camp path or thymo. To me to Erin, these are practice changing data. We will talk ourselves in circles
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode